Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,654 | 49,213 | 80,917 | 138,068 | 129,454 |
| Receivables | 119,288 | 124,963 | 105,442 | 102,029 | 89,472 |
| Inventories | 64,691 | 61,688 | 36,565 | 34,020 | 39,808 |
| TOTAL | $245,395 | $263,103 | $246,078 | $290,060 | $270,721 |
| Non-Current Assets | |||||
| PPE Net | 24,856 | 22,985 | 10,297 | 8,960 | 8,084 |
| Investments And Advances | 28,811 | 29,291 | 29,317 | 19,483 | 21,158 |
| Intangibles | 829,337 | 842,816 | 301,679 | 309,983 | 324,571 |
| Other Non-Current Assets | 68,738 | 67,667 | 67,419 | 18,150 | 18,541 |
| TOTAL | $951,742 | $962,759 | $408,712 | $356,576 | $372,354 |
| Total Assets | $1,197,137 | $1,225,862 | $654,790 | $646,636 | $643,075 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20,292 | 18,038 | 15,000 | 15,000 | 15,000 |
| Accounts payable and accrued liabilities | 22,500 | 16,915 | 10,897 | 9,881 | 10,283 |
| Accrued Expenses | 124,804 | 142,348 | 118,429 | 116,121 | 100,526 |
| Other current liabilities | 3,926 | 3,558 | 16,379 | 17,184 | 23,218 |
| TOTAL | $171,522 | $180,859 | $160,705 | $158,186 | $149,027 |
| Non-Current Liabilities | |||||
| Long Term Debt | 348,039 | 339,644 | 162,437 | 166,084 | 169,731 |
| Other Non-Current Liabilities | 43,167 | 39,581 | 54,662 | 61,246 | 55,480 |
| TOTAL | $503,697 | $511,214 | $263,588 | $269,086 | $273,766 |
| Total Liabilities | $675,219 | $692,073 | $424,293 | $427,272 | $422,793 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 77,147 | 76,389 | 75,225 | 56,849 | 56,825 |
| Common Shares | 78 | 75 | 57 | 57 | 57 |
| Retained earnings | -17,879 | -6,602 | -6,238 | -5,167 | -1,041 |
| Other shareholders' equity | 71,779 | 75,044 | 78,198 | 78,275 | 78,343 |
| TOTAL | $521,918 | $533,789 | $230,497 | $219,364 | $220,282 |
| Total Liabilities And Equity | $1,197,137 | $1,225,862 | $654,790 | $646,636 | $643,075 |